Journal of Law, Medicine and Ethics 45 (3):333-340 (2017)

Authors
Susan Wolf
University of North Carolina, Chapel Hill
Abstract
Developing ethical standards for clinical use of large-scale genome and exome sequencing has proven challenging, in part due to the inevitability of incidental or secondary findings. Policy of the American College of Medical Genetics and Genomics has evolved but remains problematic. In 2013, ACMG issued policy recommending mandatory analysis of 56 extra genes whenever sequencing was ordered for any indication, in order to ascertain positive findings in pathogenic and actionable genes. Widespread objection yielded a 2014 amendment allowing patients to opt-out from analysis of the extra genes. In 2015, ACMG published the amended policy, providing that patients could opt out of the full set of extra genes, but not a subset. In 2016, ACMG enlarged the set and indicated planned expansion of the roster of extra genes to include pharmacogenetic findings. ACMG policy does not protect the respect for patient choice that prevails in other domains of clinical medicine, where informed consent allows patients to opt in to desired testing. By creating an expanding domain of genomic testing that will be routinely conducted unless patients reject the entire set of extra tests, ACMG creates an exceptional domain clinical practice that is not supported by ethics or science.
Keywords No keywords specified (fix it)
Categories No categories specified
(categorize this paper)
DOI 10.1177/1073110517737531
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 65,784
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

Add more references

Citations of this work BETA

Controversies in Clinical Research Ethics.Robert M. Sade - 2017 - Journal of Law, Medicine and Ethics 45 (3):291-294.

Add more citations

Similar books and articles

Ethics of Evidence Based Medicine in the Primary Care Setting.A. Slowther - 2004 - Journal of Medical Ethics 30 (2):151-155.
Preventive Genomic Sequencing and Care of the Individual Patient.Danton Char - 2015 - American Journal of Bioethics 15 (7):32-33.
Managed Care at the Bedside: How Do We Look in the Moral Mirror?Edmund D. Pellegrino - 1997 - Kennedy Institute of Ethics Journal 7 (4):321-330.
Ethical Problems in Nursing.Amy Marie Haddad - 1988 - Dissertation, The University of Nebraska - Lincoln
Module Four: Standards of Care and Clinical Trials.Michael J. Selgelid - 2005 - Developing World Bioethics 5 (1):55–72.
The Clinical Ethicist at the Bedside.John Puma & David L. Schiedermayer - 1991 - Theoretical Medicine and Bioethics 12 (2).
The Inherent Paternalism in Clinical Practice.Henrik Wulff - 1995 - Journal of Medicine and Philosophy 20 (3):299-311.

Analytics

Added to PP index
2017-10-25

Total views
7 ( #1,049,562 of 2,463,136 )

Recent downloads (6 months)
1 ( #449,363 of 2,463,136 )

How can I increase my downloads?

Downloads

My notes